Thursday, November 12, 2026

AI Robotics Losses Drop 98.6% Globally as Asia, US Firms Near Commercial Launch

OMNIQ Corp cut operating losses 98.6% year-over-year while raising gross profit 60.5% in 2025, part of a global shift as AI robotics firms in North America and Asia transition from R&D to commercial deployments. Multiple companies worldwide are preparing product launches for 2026-2027, supported by new quantum-computing infrastructure and manufacturing partnerships spanning continents.

LM Salvado
LM Salvado

April 21, 2026

Source Trace Score12 source documents12 with a live linkVerifiability: High
AI Robotics Losses Drop 98.6% Globally as Asia, US Firms Near Commercial Launch
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

OMNIQ Corp reduced operating losses 98.6% year-over-year while boosting gross profit 60.5% in 2025, reflecting a global pattern as AI robotics firms from Silicon Valley to Shenzhen shift from development to commercial viability.1 The company's shareholder deficit improved 71%, from negative $43.9 million to negative $11.8 million.1

The financial turnaround mirrors developments across North America, Europe, and Asia as robotics firms prepare commercial launches for 2026-2027. AMC Robotics Corporation resolved a warrant fair value charge that cleared accounting obstacles as it prepares to scale operations.2 The company noted the warrant issue was a technical accounting matter unrelated to business performance.3

Infrastructure is expanding worldwide to support commercial AI robotics. IBM and the University of Illinois launched the IBM-Illinois Discovery Accelerator Institute, establishing quantum-centric supercomputing for AI workloads.4 The facility joins similar initiatives in Europe and Asia supporting autonomous systems moving from pilot programs to production scale.

"When you finally launch the thing you've been working on, and you see the usage go up, it's exhilarating," said Sarang Gupta, an OpenAI engineer, describing the shift from development to adoption.5 His comments reflect sentiment across the global robotics sector as applications transition to real-world deployments.

The commercialization wave spans humanoid robots, autonomous vehicles, and enterprise AI tools across continents. Companies are moving beyond demonstrations to manufacturing partnerships and revenue generation. OMNIQ's gross profit increase shows customers globally are paying for AI robotics solutions at scale rather than running limited trials.

The 2026-2027 period marks an inflection point where years of international AI robotics R&D investment convert to operational systems. Financial metrics suggest the sector worldwide is crossing from cash-burning development to sustainable commercial operations.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score12 source documents12 with a live linkVerifiability: High
  1. [1]SEC filingGlobeNewswire· April 15, 2026
    AMC Robotics Announces Delay in Filing Annual Report on Form 10-K
  2. [2]Press releaseGlobeNewswire· April 21, 2026
    AMC Robotics Reports Full Year 2025 Financial Results
  3. [3]News articleYahoo Finance· April 16, 2026
    IBM and the University of Illinois Urbana-Champaign Expand Discovery Accelerator Institute to Advance AI and Quantum Computing
  4. [4]Press releaseGlobeNewswire· April 15, 2026
    OMNIQ Reports 60% Increase in Gross Profit for 2025
  5. [5]News articleIEEE Spectrum
    OpenAI Engineer Helps Companies Attract Buyers and Boost Sales
  6. [6]Press releaseGlobeNewswire· March 26, 2026
    2026 Louisiana Energy Conference to Be Held May 26- 28 at the Four Seasons Hotel in New Orleans
  7. [7]News articleCrunchbase News
    5 Interesting Startup Deals You May Have Missed: A Credit Card Backed By Mineral Rights, Flying Ferries, And A Foundation AI Model For Plants
  8. [8]News articleNasdaq· April 19, 2026
    Got $5,000? Here's the 1 "Magnificent Seven" Stock I'd Buy While It's 25% Off Its Highs
  9. [9]News articleIEEE Spectrum
    IEEE Entrepreneurship Connects Hardware Startups With Investors
  10. [10]Press releaseGlobeNewswire· April 17, 2026
    Intchains Group Limited Provides Staking Activities Update; Advances Strategic Transformation with AI-Enabled Operating Model to Enhance Efficiency and Productivity
  11. [11]News articleYahoo Finance· April 16, 2026
    Nissan Advances AI and EV Strategy, Cuts Model Lineup to 45
  12. [12]News articleYahoo Finance· April 17, 2026
    NuScale Powers Up 11%, Oklo Climbs 6%, Nano Nuclear Rises 5% as the Nuclear Sector Posts Back-to-Back Rallies

In this story · Knowledge Files

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com